Literature DB >> 28013367

Actin polymerization plays a significant role in asbestos-induced inflammasome activation in mesothelial cells in vitro.

Maximilian MacPherson1, Catherine Westbom1, Helen Kogan1, Arti Shukla2.   

Abstract

Asbestos exposure leads to malignant mesothelioma (MM), a deadly neoplasm of mesothelial cells of various locations. Although there is no doubt about the role of asbestos in MM tumorigenesis, mechanisms are still not well explored. Recently, our group demonstrated that asbestos causes inflammasome priming and activation in mesothelial cells, which in part is dependent on oxidative stress. Our current study sheds light on yet another mechanism of inflammasome activation by asbestos. Here we show the role of actin polymerization in asbestos-induced activation of the nod-like receptor pyrin domain-containing protein 3 (NLRP3) inflammasome. Using human mesothelial cells, we first demonstrate that asbestos and carbon nanotubes induced caspase-1 activation and high-mobility group box 1, interleukin 1 beta and interleukin 18 secretion was blocked by Cytochalasin D (Cyto D) an actin polymerization inhibitor. Next, to understand the mechanism, we assessed whether phagocytosis of fibers by mesothelial cells is affected by actin polymerization inhibition. Transmission electron microscopy showed the inhibition of fiber uptake by mesothelial cells in the presence of Cyto D. Furthermore, localization of components of the inflammasome, apoptotic speck-like protein containing a CARD domain (ASC) and NLRP3, to the perinuclear space in mitochondria or endoplasmic reticulum in response to fiber exposure was also interrupted in the presence of Cyto D. Taken together, our studies suggest that actin polymerization plays important roles in inflammasome activation by fibers via regulation of phagocytosis and/or spatial localization of inflammasome components.

Entities:  

Keywords:  Actin polymerization; Asbestos; Inflammasome; Mesothelial cells

Mesh:

Substances:

Year:  2016        PMID: 28013367      PMCID: PMC5401653          DOI: 10.1007/s00418-016-1530-8

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  15 in total

1.  A role for mitochondria in NLRP3 inflammasome activation.

Authors:  Rongbin Zhou; Amir S Yazdi; Philippe Menu; Jürg Tschopp
Journal:  Nature       Date:  2010-12-01       Impact factor: 49.962

2.  CREB-induced inflammation is important for malignant mesothelioma growth.

Authors:  Catherine M Westbom; Anurag Shukla; Maximilian B MacPherson; Elizabeth C Yasewicz; Jill M Miller; Stacie L Beuschel; Chad Steele; Harvey I Pass; Pamela M Vacek; Arti Shukla
Journal:  Am J Pathol       Date:  2014-08-08       Impact factor: 4.307

3.  Thioredoxin-interacting protein links oxidative stress to inflammasome activation.

Authors:  Rongbin Zhou; Aubry Tardivel; Bernard Thorens; Inpyo Choi; Jürg Tschopp
Journal:  Nat Immunol       Date:  2009-12-20       Impact factor: 25.606

4.  Apoptosis is observed in mesothelial cells after exposure to crocidolite asbestos.

Authors:  K A BéruBé; T R Quinlan; H Fung; J Magae; P Vacek; D J Taatjes; B T Mossman
Journal:  Am J Respir Cell Mol Biol       Date:  1996-07       Impact factor: 6.914

5.  Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica.

Authors:  Catherine Dostert; Virginie Pétrilli; Robin Van Bruggen; Chad Steele; Brooke T Mossman; Jürg Tschopp
Journal:  Science       Date:  2008-04-10       Impact factor: 47.728

6.  Inhalation Exposure to Carbon Nanotubes (CNT) and Carbon Nanofibers (CNF): Methodology and Dosimetry.

Authors:  Günter Oberdörster; Vincent Castranova; Bahman Asgharian; Phil Sayre
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2015       Impact factor: 6.393

7.  Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization.

Authors:  Veit Hornung; Franz Bauernfeind; Annett Halle; Eivind O Samstad; Hajime Kono; Kenneth L Rock; Katherine A Fitzgerald; Eicke Latz
Journal:  Nat Immunol       Date:  2008-07-11       Impact factor: 25.606

Review 8.  Inflammasomes: current understanding and open questions.

Authors:  Franz Bauernfeind; Andrea Ablasser; Eva Bartok; Sarah Kim; Jonathan Schmid-Burgk; Taner Cavlar; Veit Hornung
Journal:  Cell Mol Life Sci       Date:  2010-10-31       Impact factor: 9.207

9.  Inflammasome Modulation by Chemotherapeutics in Malignant Mesothelioma.

Authors:  Catherine Westbom; Joyce K Thompson; Alan Leggett; Maximilian MacPherson; Stacie Beuschel; Harvey Pass; Pamela Vacek; Arti Shukla
Journal:  PLoS One       Date:  2015-12-21       Impact factor: 3.240

10.  Asbestos modulates thioredoxin-thioredoxin interacting protein interaction to regulate inflammasome activation.

Authors:  Joyce K Thompson; Catherine M Westbom; Maximilian B MacPherson; Brooke T Mossman; Nicholas H Heintz; Page Spiess; Arti Shukla
Journal:  Part Fibre Toxicol       Date:  2014-05-20       Impact factor: 9.400

View more
  4 in total

Review 1.  Cells under stress: The mechanical environment shapes inflammasome responses to danger signals.

Authors:  Hemant Joshi; Sharon Celeste Morley
Journal:  J Leukoc Biol       Date:  2019-01-15       Impact factor: 4.962

Review 2.  Crosstalk between ER stress, NLRP3 inflammasome, and inflammation.

Authors:  Wei Li; Ting Cao; Chunyi Luo; Jialun Cai; Xiangping Zhou; Xinhua Xiao; Shuangquan Liu
Journal:  Appl Microbiol Biotechnol       Date:  2020-05-24       Impact factor: 4.813

Review 3.  Role of Inflammasomes in Keloids and Hypertrophic Scars-Lessons Learned from Chronic Diabetic Wounds and Skin Fibrosis.

Authors:  Chenyu Huang; Rei Ogawa
Journal:  Int J Mol Sci       Date:  2022-06-19       Impact factor: 6.208

4.  α-Synuclein evokes NLRP3 inflammasome-mediated IL-1β secretion from primary human microglia.

Authors:  Adrianne F Pike; Tatiana Varanita; Maaike A C Herrebout; Bonnie C Plug; Jeroen Kole; René J P Musters; Charlotte E Teunissen; Jeroen J M Hoozemans; Luigi Bubacco; Robert Veerhuis
Journal:  Glia       Date:  2021-01-28       Impact factor: 7.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.